Fr430 GASTRIC ACCOMMODATION IN PATIENTS WITH PARKINSON'S DISEASE AND UPPER GASTROINTESTINAL SYMPTOMS

2021 ◽  
Vol 160 (6) ◽  
pp. S-315
Author(s):  
Jessica Atieh ◽  
Michael Camilleri
2003 ◽  
Vol 124 (4) ◽  
pp. A53
Author(s):  
Albert J. Bredenoord ◽  
Heather J. Chial ◽  
Michael Camilleri ◽  
Brian P. Mullan ◽  
Joseph A. Murray

Nutrients ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 3740
Author(s):  
Tanisa Patcharatrakul ◽  
Chatchai Kriengkirakul ◽  
Tawatchai Chaiwatanarat ◽  
Sutep Gonlachanvit

The effects of chili on gastric accommodation (GA) in gastroesophageal reflux disease (GERD) patients have not been explored. Methods: In total, 15 healthy volunteers (HV) and 15 pH-positive non-erosive GERD (NERD) patients underwent single-photon emission computed tomography after ingesting 2 g of chili or placebo in capsules in a randomized double-blind crossover fashion with a one-week washout period. GA was the maximal postprandial gastric volume (GV) after 250 mL of Ensure® minus the fasting GV. Upper gastrointestinal symptoms were evaluated by using a visual analog scale. Results: NERD patients but not HV had significantly greater GA after chili compared to a placebo (451 ± 89 vs. 375 ± 81 mL, p < 0.05). After chili, the postprandial GVs at 10, 20, and 30 min in NERD patients were significantly greater than HV (10 min, 600 ± 73 vs. 526 ± 70 mL; 20 min, 576 ± 81 vs. 492 ± 78 mL; 30 min, 532 ± 81 vs. 466 ± 86 mL, all p < 0.05). In NERD, chili was associated with significantly less satiety, more severe abdominal burning (p < 0.05), and a trend of more severe heartburn (p = 0.06) compared to the placebo. In HV, postprandial symptoms after chili and placebo ingestion were similar (p > 0.05). Conclusions: Chili enhanced GA in NERD patients but not in HV. This suggests that the modulation of GA in NERD is abnormal and likely involves transient receptor potential vanilloid 1 (TRPV1) sensitive pathways.


2003 ◽  
Vol 1 (4) ◽  
pp. 264-272 ◽  
Author(s):  
Albert J Bredenoord ◽  
Heather J Chial ◽  
Michael Camilleri ◽  
Brian P Mullan ◽  
Joseph A Murray

2003 ◽  
Vol 1 (4) ◽  
pp. 264-272 ◽  
Author(s):  
Albert J. Bredenoord ◽  
Heather J. Chial ◽  
Michael Camilleri ◽  
Brian P. Mullan ◽  
Joseph A. Murray

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Stefano Romano ◽  
George M. Savva ◽  
Janis R. Bedarf ◽  
Ian G. Charles ◽  
Falk Hildebrand ◽  
...  

AbstractThe gut microbiota is emerging as an important modulator of neurodegenerative diseases, and accumulating evidence has linked gut microbes to Parkinson’s disease (PD) symptomatology and pathophysiology. PD is often preceded by gastrointestinal symptoms and alterations of the enteric nervous system accompany the disease. Several studies have analyzed the gut microbiome in PD, but a consensus on the features of the PD-specific microbiota is missing. Here, we conduct a meta-analysis re-analyzing the ten currently available 16S microbiome datasets to investigate whether common alterations in the gut microbiota of PD patients exist across cohorts. We found significant alterations in the PD-associated microbiome, which are robust to study-specific technical heterogeneities, although differences in microbiome structure between PD and controls are small. Enrichment of the genera Lactobacillus, Akkermansia, and Bifidobacterium and depletion of bacteria belonging to the Lachnospiraceae family and the Faecalibacterium genus, both important short-chain fatty acids producers, emerged as the most consistent PD gut microbiome alterations. This dysbiosis might result in a pro-inflammatory status which could be linked to the recurrent gastrointestinal symptoms affecting PD patients.


Sign in / Sign up

Export Citation Format

Share Document